The Children’s Hospital of Philadelphia
“At Children’s Hospital of Philadelphia, we know that getting a comprehensive view of our patients is crucial to delivering the best possible care, based on the most innovative research. Combining multiple clinical modalities is foundational to achieving this. With Amazon Omics, we can expand our understanding of our patients’ health, all the way down to their DNA.”
Jeff Pennington, Associate Vice President, Chief Research Informatics Officer, The Children’s Hospital of Philadelphia
C2i Genomics
“In C2i Genomics, we empower our data scientists by providing them cloud-based computational solutions to run high-scale, customizable genomic pipelines, allowing them to focus on method development and clinical performance, while the company’s engineering teams are responsible for the operations, security, and privacy aspects of the workloads. Amazon Omics allows researchers to use tools and languages from their own domain and considerably reduces the engineering maintenance effort while taking care of cost and resource allocation considerations, which, in turn, reduce time-to-market and NRE costs of new features and algorithmic improvements.”
Ury Alon, VP of Engineering, C2i Genomics
G42 Healthcare
“Amazon Omics allows G42 to accelerate a competitive and deployable end-to-end service with globally leading data governance. We’re able to leverage the extensive omics data management and bioinformatics solutions hosted globally on AWS, at our customers’ fingertips. Our collaboration with AWS is much more than data—it’s about value.”
Ashish Koshy, CEO, G42 Healthcare
Ovation
“At Ovation, we want to make it easier for patients to live long and healthy lives by accessing therapeutics that are tailored to their needs. Being a part of the Amazon Omics genomic variant store helps us achieve that mission by getting our genomic data into the hands of researchers faster and at scale. We’re excited to be building a team of industry experts and partners like AWS that are helping personalized medicines get to market quicker.”
Curt Medeiros, Chief Executive Officer, Ovation
Element Biosciences
“Element Biosciences is opening the world of biology to new possibilities through Element's AVITI system. Amazon Omics provides a simple solution for running workflows in the cloud and this will enable the scientific community to easily process their sequencing data without the need to set up any infrastructure, allowing them to focus on their research."
Francisco Garcia, SVP of Software and Informatics, Element Biosciences
Ultima Genomics
“Ultima Genomics is unleashing the power of genomics at scale. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information. We are excited to work with AWS to help our customers to scale secondary analysis with Amazon Omics.”
Omer Barad, VP of Genomic Solutions, Ultima Genomics
Sentieon
“At Sentieon, we are dedicated to enabling precision data for precision medicine. Amazon Omics simplifies the infrastructure setup to run Sentieon’s suite of bioinformatics secondary analysis tools. We look forward to offering our analysis workflows on Amazon Omics.”
Brendan Gallagher, Head of Business Development, Sentieon
BioTeam
“BioTeam is a life sciences IT consulting company passionate about accelerating scientific discovery by closing the gap between what scientists want to do with data and what they can do. We look forward to utilizing Amazon Omics as one of our tools to help simplify automating the collection, organization, and transformation of data from large genomic sequencing efforts for our clients.”
William Van Etten, Co-founder and Senior Scientific Consultant, BioTeam